Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study

Adv Exp Med Biol. 1994:353:193-202. doi: 10.1007/978-1-4615-2443-4_18.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Animals
  • Antibodies, Anti-Idiotypic / biosynthesis*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Neoplasm / immunology*
  • Antibody Formation / drug effects
  • Female
  • Guanidines / adverse effects
  • Guanidines / pharmacokinetics
  • Guanidines / pharmacology
  • Guanidines / therapeutic use*
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Male
  • Mice
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasms / immunology*
  • Recombinant Fusion Proteins / immunology
  • Species Specificity

Substances

  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Guanidines
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • gusperimus